Phase III Adjuvant Chemotherapy with Intensive CEF (CTX/EPI/5-FU) vs Standard CMF (CTX/MTX/5-FU) in Premenopausal Patients with Carcinoma of the Breast with Positive Axillary Nodes
Back to Top
Basic Trial Information
Trial Contact Information
| Phase | Type | Status | Age | Sponsor | Protocol IDs |
|---|---|---|---|---|---|
| Phase III | Treatment | Closed | pre/perimenopausal | CAN-NCIC-MA5 NCI-V90-0027, MA5 |
Trial Lead Organizations
NCIC-Clinical Trials Group
 | | | |
| Mark Levine, MD, Protocol chair (Contact information may not be current) | |
| |
| |||
Back to Top
